Cargando…
Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization
PURPOSE: To assess the 5-year visual outcome of intravitreal bevacizumab in inflammatory ocular neovascularization. METHODS: Retrospective, multicenter, consecutive case series of eight patients with inflammatory ocular neovascularization refractory to standard therapy who were treated with intravit...
Autores principales: | Mansour, Ahmad M, Mackensen, Friederike, Mahendradas, Padmamalini, Khairallah, Moncef, Lai, Timothy YY, Bashshur, Ziad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422149/ https://www.ncbi.nlm.nih.gov/pubmed/22927733 http://dx.doi.org/10.2147/OPTH.S34294 |
Ejemplares similares
-
Combined intravitreal bevacizumab with phacoemulsification in visually significant cataract and visually significant exudative maculopathy
por: Mansour, Ahmad, et al.
Publicado: (2011) -
Anterior segment changes following intravitreal bevacizumab injection for treatment of neovascular glaucoma
por: Canut, MI, et al.
Publicado: (2011) -
Long-term outcomes of intravitreal injection of bevacizumab for choroidal neovascularization associated with choroidal osteoma
por: Yoshikawa, Tadanobu, et al.
Publicado: (2015) -
Intravitreal Bevacizumab (Avastin) Treatment of Neovascular Glaucoma in Ocular Ischemic Syndrome
por: Lee, Sang Joon, et al.
Publicado: (2009) -
Intravitreal bevacizumab as therapy for refractory neovascular glaucoma secondary to iris metastasis of breast carcinoma
por: Vale, Stephanie, et al.
Publicado: (2018)